Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7004203 | 0.76 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL5093325 | 0.74 | GRIN1 (0.38) | — | |
| SCHEMBL5095702 | 0.72 | — | — | |
| SCHEMBL6012195 | 0.71 | PKM (0.36) | HSD11B1 | |
| SCHEMBL424435 | 0.69 | PKM (0.42) | HSD11B1 | |
| SCHEMBL4003953 | 0.69 | GRIN2D (0.36) | HSD11B1 | |
| SCHEMBL2748069 | 0.68 | DPP4 (0.32) | — | |
| SCHEMBL25472233 | 0.67 | GRIN1 (0.52) | — | |
| SCHEMBL986905 | 0.67 | GRIN1 (0.46) | — | |
| SCHEMBL733948 | 0.67 | GRIN1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7470824-B2 | Adamantane derivative and process for producing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20060149073-A1 | Adamantane derivative and process for producing the same | IDEMITSU KOSAN CO. (JP) | 2006-07-06 | — | — | US | disclosed |
| EP-1577285-A1 | ADAMANTANE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2005-09-21 | — | — | EP | disclosed |
| EP-1081150-B1 | 4-Oxatricyclo(4.3.1.1-3,8)undecan-5-one derivatives and process for producing the same | DAICEL CHEM (JP) | 2003-10-29 | — | — | EP | disclosed |
| US-6486330-B1 | 4-oxatricyclo[4.3.1.1 3,8]undecan-5-one derivative and process for producing the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-26 | — | — | US | disclosed |
| EP-1081150-A1 | 4-Oxatricyclo(4.3.1.1-3,8)undecan-5-one derivatives and process for producing the same | Daicel Chemical Industries, Ltd. (JP) | 2001-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149073-A1 | Adamantane derivative and process for producing the same | PADI1, BACE1, CHRM1 | HSD11B1 861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.